Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
FEATURED NOTICE | |
City of Elma 2024 Red Town Initiative Surface Treatment | |
New Bid Calls | 12 |
New Consultant Notices | 3 |
New Supply Bids | 0 |
CAB INSTRUCTIONAL KITCHEN RENOVATION - SOUTH SEATTLE COLLEGE Kassel & Associates |
SR 3, SR 16 AND SR 166, GORST VICINITY - REMOVE FISH BARRIERS - WSDOT Kiewit Infrastructure West Co. |
PORT OF NOME MODIFICATION PHASE 1, NOME, AK - U.S. ARMY ENGINEER DISTRICT, AK Kiewit Infrastructure West Co. |
SSA TERMINAL 5 GATE COMPLEX PCL Construction Services, Inc. |
EXPLORER MIDDLE SCHOOL, BID SET 1, BP 5.1, 5.2 Cornerstone General Contractors |
more » |
print email to a friend reprints add to mydjc |
August 13, 2020
Seattle-based biopharmaceutical company Omeros priced an offering of 6.9 million shares of common stock at $14.50 per share and a separate offering of $210 million in 5.25% convertible senior notes due in 2026. The offerings are expected to close on Friday and include options to purchase up to 1.04 million additional shares and $31.5 million in notes. Omeros will use $297.4 million in net proceeds for general corporate purposes and to repurchase about $115 million of existing 6.25% convertible senior notes due in 2023.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2024 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index